During a fecal matter transfer (FMT), non-pathogenic viruses were transferred from a healthy patient to three pediatric ulcerative colitis (UC) patients, according to findings published in mBio.
Physicians trying to improve quality of life for their COPD patients may find telemhealth techniques like scheduled phone check-ins useful, but studies have yet to show a clear benefit.
The history of botulinum toxins dates back hundreds of years. What it can mean for the future of medicine and what conditions it can help in the future remains to be seen.
In this segment, Drs. Lublin, Coyle, Markowitz, and Riley discuss the benefits of initiating treatment sooner into a multiple sclerosis diagnosis. Dr. Riley suggests that patient-physician communication may be effective in empowering newly-diagnosed patients to stay adherent to therapy, especially in scenarios where treatment occurs early in one’s disease course.
Rare structural variants in genes could be contributing to the pathogenesis of ulcerative colitis.
Watch as Drs. Lublin, Coyle, Markowitz, and Riley explore the pathophysiologic, genetic, and environmental factors that are thought to play a role in the development and progression of multiple sclerosis, and discuss how new revelations are improving strategies for treating and managing the condition.
As with many parts of medicine guidelines are constantly being updated across a variety of specialties. The American Academy of Neurology recently released new guidance on how and when to use botulinum toxin in patient care.
Researchers from the University of North Carolina (UNC) analyzed how the human immunodeficiency virus (HIV) attacks macrophages – a target that, up until now, was believed to have little to do with infection.
An oxycodone (Xtampza) extended-release (ER) product is the newest opioid soon to be on the market for chronic pain.